BDTX-1535 is a potent, selective, brain penetrant and irreversible MasterKey inhibitor of EGFR mutations that expressed in glioblastoma multiforme (GBM) and intrinsic and acquired resistance EGFR mutations in non-small cell lung cancer (NSCLC).

Cat# orb1910245-250mg

Size : 250mg

Marca : Biorbyt

Richiedere ulteriori informazioni

Contatta il distributore locale :


Telefono : +1 850 650 7790